SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 55 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $165,000 | -68.9% | 190,240 | -16.8% | 0.00% | – |
| Q1 2019 | $530,000 | -32.1% | 228,531 | -32.1% | 0.00% | – |
| Q4 2018 | $780,000 | -67.4% | 336,438 | +108.3% | 0.00% | -100.0% |
| Q3 2018 | $2,393,000 | +83.7% | 161,520 | +88.2% | 0.00% | – |
| Q2 2018 | $1,303,000 | -0.2% | 85,814 | +23.5% | 0.00% | – |
| Q1 2018 | $1,305,000 | +59.3% | 69,501 | +53.9% | 0.00% | – |
| Q4 2017 | $819,000 | -7.1% | 45,153 | +13.9% | 0.00% | – |
| Q3 2017 | $882,000 | – | 39,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|